Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ronald Steven Arellano, M.D.

Co-Author

This page shows the publications co-authored by Ronald Arellano and Raul Uppot.
Connection Strength

3.971
  1. Microwave Ablation as Bridging Therapy for Patients with Hepatocellular Carcinoma Awaiting Liver Transplant: A Single Center Experience. Cardiovasc Intervent Radiol. 2021 Jul 06.
    View in: PubMed
    Score: 0.249
  2. Thermal Ablation of Renal Cell Carcinoma in Patients With Morbid Obesity: Assessment of Technique, Safety, and Oncologic Outcomes. AJR Am J Roentgenol. 2021 04; 216(4):989-996.
    View in: PubMed
    Score: 0.243
  3. Impact of Body Mass Index on Perioperative Complications and Oncologic Outcomes in Patients Undergoing Thermal Ablation for Renal Cell Carcinoma. J Vasc Interv Radiol. 2021 01; 32(1):33-38.
    View in: PubMed
    Score: 0.240
  4. Early trends and predictors of renal function following computed tomography-guided percutaneous cryoablation of a renal mass in patients with and without prior renal impairment. Radiol Bras. 2020 May-Jun; 53(3):141-147.
    View in: PubMed
    Score: 0.230
  5. CT Texture Analysis and Machine Learning Improve Post-ablation Prognostication in Patients with Adrenal Metastases: A Proof of Concept. Cardiovasc Intervent Radiol. 2019 Dec; 42(12):1771-1776.
    View in: PubMed
    Score: 0.220
  6. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes. J Vasc Interv Radiol. 2019 Jul; 30(7):1035-1042.
    View in: PubMed
    Score: 0.213
  7. Risk Assessment of Chronic Kidney Disease following Microwave Ablation for Stage T1 Renal Cell Carcinoma. J Vasc Interv Radiol. 2018 12; 29(12):1685-1691.
    View in: PubMed
    Score: 0.206
  8. CT-Guided Percutaneous Needle Biopsy of Retroperitoneal and Pelvic Lymphadenopathy: Assessment of Technique, Diagnostic Yield, and Clinical Value. J Vasc Interv Radiol. 2018 10; 29(10):1429-1436.
    View in: PubMed
    Score: 0.205
  9. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients. Cardiovasc Intervent Radiol. 2018 Nov; 41(11):1743-1750.
    View in: PubMed
    Score: 0.200
  10. Local Control and Survival after Image-Guided Percutaneous Ablation of Adrenal Metastases. J Vasc Interv Radiol. 2018 02; 29(2):276-284.
    View in: PubMed
    Score: 0.192
  11. Imaging guided percutaneous interventions in hepatic dome lesions: Tips and tricks. World J Hepatol. 2017 Jul 08; 9(19):840-849.
    View in: PubMed
    Score: 0.189
  12. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center. AJR Am J Roentgenol. 2017 Oct; 209(4):733-739.
    View in: PubMed
    Score: 0.189
  13. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors. J Vasc Interv Radiol. 2017 Dec; 28(12):1643-1650.
    View in: PubMed
    Score: 0.189
  14. Use of an Electromagnetic Navigation System on a Phantom as a Training Simulator for CT-Guided Procedures. J Am Coll Radiol. 2017 06; 14(6):795-799.
    View in: PubMed
    Score: 0.184
  15. Navigational Guidance and Ablation Planning Tools for Interventional Radiology. Curr Probl Diagn Radiol. 2017 May - Jun; 46(3):225-233.
    View in: PubMed
    Score: 0.181
  16. CT-Guided Percutaneous Microwave Ablation of Tumors in the Hepatic Dome: Assessment of Efficacy and Safety. J Vasc Interv Radiol. 2016 Apr; 27(4):496-502; quiz 503.
    View in: PubMed
    Score: 0.172
  17. Catecholamine Surge during Image-Guided Ablation of Adrenal Gland Metastases: Predictors, Consequences, and Recommendations for Management. J Vasc Interv Radiol. 2016 Mar; 27(3):395-402.
    View in: PubMed
    Score: 0.170
  18. Image-guided percutaneous thermal ablation of metastatic pelvic tumor from gynecologic malignancies. Obstet Gynecol. 2014 Mar; 123(3):500-505.
    View in: PubMed
    Score: 0.150
  19. Thermal Ablation, Embolization, and Selective Internal Radiation Therapy Combined with Checkpoint Inhibitor Cancer Immunotherapy: Safety Analysis. J Vasc Interv Radiol. 2021 02; 32(2):187-195.
    View in: PubMed
    Score: 0.060
  20. TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma. Cancer Discov. 2019 08; 9(8):1064-1079.
    View in: PubMed
    Score: 0.054
  21. Radiation Dose and Risk Estimates of CT-Guided Percutaneous Liver Ablations and Factors Associated with Dose Reduction. Cardiovasc Intervent Radiol. 2018 Dec; 41(12):1935-1942.
    View in: PubMed
    Score: 0.051
  22. Impact of Dose-Modified Protocols on Radiation Doses in Patients Undergoing CT Examinations following Image-Guided Catheter Placement. J Vasc Interv Radiol. 2015 Sep; 26(9):1339-46.e1.
    View in: PubMed
    Score: 0.041
  23. Prospective trial with optical molecular imaging for percutaneous interventions in focal hepatic lesions. Radiology. 2015 Mar; 274(3):917-26.
    View in: PubMed
    Score: 0.039
  24. Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol. 2010 Apr; 20(4):877-85.
    View in: PubMed
    Score: 0.028
  25. Percutaneous hepatic abscess drainage: do multiple abscesses or multiloculated abscesses preclude drainage or affect outcome? J Vasc Interv Radiol. 2009 Aug; 20(8):1059-65.
    View in: PubMed
    Score: 0.027
  26. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol. 2008 Jul; 19(7):1034-40.
    View in: PubMed
    Score: 0.025
  27. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage. Radiology. 2008 Mar; 246(3):956-63.
    View in: PubMed
    Score: 0.025
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.